Neural stem cells derived from primitive mesenchymal stem cells reversed disease symptoms and promoted neurogenesis in an experimental autoimmune encephalomyelitis mouse model of multiple sclerosis.
Neural stem cells derived from primitive mesenchymal stem cells reversed disease symptoms and promoted neurogenesis in an experimental autoimmune encephalomyelitis mouse model of multiple sclerosis.
复制标题
来源于原始间充质干细胞的神经干细胞在多发性硬化症的实验性自身免疫性脑脊髓炎小鼠模型中逆转疾病症状并促进神经发生。
DOI:
10.1186/s13287-021-02563-8
复制
发表时间:
2021-09-09
影响因子:
7.5
通讯作者:
Chaudhry GR
中科院分区:
文献类型:
--
作者:
Brown C;McKee C;Halassy S;Kojan S;Feinstein DL;Chaudhry GR
Multiple sclerosis (MS) is an autoimmune inflammatory disease of the central nervous system (CNS). MS affects millions of people and causes a great economic and societal burden. There is no cure for MS. We used a novel approach to investigate the therapeutic potential of neural stem cells (NSCs) derived from human primitive mesenchymal stem cells (MSCs) in an experimental autoimmune encephalomyelitis (EAE) mouse model of MS. MSCs were differentiated into NSCs, labeled with PKH26, and injected into the tail vein of EAE mice. Neurobehavioral changes in the mice assessed the effect of transplanted cells on the disease process. The animals were sacrificed two weeks following cell transplantation to collect blood, lymphatic, and CNS tissues for analysis. Transplanted cells were tracked in various tissues by flow cytometry. Immune infiltrates were determined and characterized by H&E and immunohistochemical staining, respectively. Levels of immune regulatory cells, Treg and Th17, were analyzed by flow cytometry. Myelination was determined by Luxol fast blue staining and immunostaining. In vivo fate of transplanted cells and expression of inflammation, astrogliosis, myelination, neural, neuroprotection, and neurogenesis markers were investigated by using immunohistochemical and qRT-PCR analysis. MSC-derived NSCs expressed specific neural markers, NESTIN, TUJ1, VIMENTIN, and PAX6. NSCs improved EAE symptoms more than MSCs when transplanted in EAE mice. Post-transplantation analyses also showed homing of MSCs and NSCs into the CNS with concomitant induction of an anti-inflammatory response, resulting in reducing immune infiltrates. NSCs also modulated Treg and Th17 cell levels in EAE mice comparable to healthy controls. Luxol fast blue staining showed significant improvement in myelination in treated mice. Further analysis showed that NSCs upregulated genes involved in myelination and neuroprotection but downregulated inflammatory and astrogliosis genes more significantly than MSCs. Importantly, NSCs differentiated into neural derivatives and promoted neurogenesis, possibly by modulating BDNF and FGF signaling pathways. NSC transplantation reversed the disease process by inducing an anti-inflammatory response and promoting myelination, neuroprotection, and neurogenesis in EAE disease animals. These promising results provide a basis for clinical studies to treat MS using NSCs derived from primitive MSCs. The online version contains supplementary material available at 10.1186/s13287-021-02563-8.
登录
查看更多内容
影响因子:
7.5
作者:
Bravo B;Gallego MI;Flores AI;Bornstein R;Puente-Bedia A;Hernández J;de la Torre P;García-Zaragoza E;Perez-Tavarez R;Grande J;Ballester A;Ballester S
通讯作者:
Ballester S
影响因子:
1.6
作者:
Alghwiri, Alia A.;Jamali, Fatima;Awidi, Abdalla
通讯作者:
Awidi, Abdalla
影响因子:
5.3
作者:
Duffy, Samuel S.;Keating, Brooke A.;Moalem-Taylor, Gila
通讯作者:
Moalem-Taylor, Gila
影响因子:
5.6
作者:
Kanakasabai, Saravanan;Casalini, Eli;Bright, John J.
通讯作者:
Bright, John J.
影响因子:
5.4
作者:
Glatigny, Simon;Bettelli, Estelle
通讯作者:
Bettelli, Estelle